Premium
Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide
Author(s) -
Harrison Claire N.,
Griesshammer Martin,
Miller Carole,
Masszi Tamas,
Passamonti Francesco,
Zachee Pierre,
Durrant Simon,
Pane Fabrizio,
Guglielmelli Paola,
Verstovsek Srdan,
Jones Mark M.,
Hunter Deborah S.,
Sun William,
Li Jingjin,
Khan Mahmudul,
Habr Dany,
Kiladjian JeanJacques
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14764
Subject(s) - polycythaemia , hydroxycarbamide , ruxolitinib , medicine , polycythemia vera , anagrelide , hematology , jak2 v617f , myelofibrosis , disease , essential thrombocythemia , bone marrow